Franklin Street Advisors Inc Pfizer Inc Transaction History

Franklin Street Advisors Inc

$1.42 Billion
Q1 2025

A detailed history of Franklin Street Advisors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Franklin Street Advisors Inc holds 43,163 shares of PFE stock, worth $954,765. This represents 0.08% of its overall portfolio holdings.

Number of Shares

43,163

Previous 43,153 0.02%

Holding current value

$954,765

Previous $1.15 Million 4.45%

% of portfolio

0.08%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$25.01 - $27.13 $250 - $271	10 Added 0.02%	43,163 $1.09 Million
Q4 2024 Jan 10, 2025	SELL	$24.8 - $30.19 $327,087 - $398,175	-13,189 Reduced 23.41%	43,153 $1.15 Million
Q3 2024 Oct 09, 2024	BUY	$27.7 - $31.39 $377,911 - $428,253	13,643 Added 31.95%	56,342 $1.63 Million
Q2 2024 Jul 18, 2024	SELL	$25.26 - $29.6 $31,448 - $36,852	-1,245 Reduced 2.83%	42,699 $1.2 Million
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $13,411 - $15,400	-518 Reduced 1.17%	43,944 $1.22 Million
Q4 2023 Jan 18, 2024	BUY	$26.13 - $33.94 $2,534 - $3,292	97 Added 0.22%	44,462 $1.28 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $13,830 - $16,166	-431 Reduced 0.96%	44,365 $1.47 Million
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $436,040 - $504,488	12,072 Added 36.89%	44,796 $1.64 Million
Q1 2023 Apr 12, 2023	SELL	$39.39 - $51.28 $202,897 - $264,143	-5,151 Reduced 13.6%	32,724 $1.34 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $47,386 - $61,857	-1,135 Reduced 2.91%	37,875 $1.94 Million
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $12,340 - $15,064	282 Added 0.73%	39,010 $1.71 Million
Q2 2022 Jul 13, 2022	SELL	$46.53 - $55.17 $2.01 Million - $2.39 Million	-43,284 Reduced 52.78%	38,728 $2.03 Million
Q1 2022 Apr 18, 2022	SELL	$45.75 - $56.69 $1.53 Million - $1.89 Million	-33,351 Reduced 28.91%	82,012 $4.25 Million
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $188,501 - $279,422	4,562 Added 4.12%	115,363 $6.81 Million
Q3 2021 Oct 22, 2021	SELL	$39.25 - $50.42 $76,262 - $97,966	-1,943 Reduced 1.72%	110,801 $4.77 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $581,706 - $658,975	-16,199 Reduced 12.56%	112,744 $4.42 Million
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $6.74 Million - $7.61 Million	-201,387 Reduced 60.97%	128,943 $4.67 Million
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $4.19 Million - $5.33 Million	125,253 Added 61.08%	330,330 $12.2 Million
Q3 2020 Oct 21, 2020	BUY	$31.75 - $37.25 $5.69 Million - $6.67 Million	179,147 Added 690.89%	205,077 $7.53 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $9,457 - $11,473	-314 Reduced 1.2%	25,930 $848,000
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $122,608 - $175,180	-4,536 Reduced 14.74%	26,244 $857,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $4,674 - $5,305	-142 Reduced 0.46%	30,780 $1.21 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $112,902 - $146,401	-3,475 Reduced 10.1%	30,922 $1.11 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $20,228 - $22,711	-547 Reduced 1.57%	34,397 $1.49 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $15,750 - $17,304	-420 Reduced 1.19%	34,944 $1.48 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $12,002 - $13,684	-312 Reduced 0.87%	35,364 $1.54 Million
Q3 2018 Oct 05, 2018	BUY	$34.47 - $41.81 $151,288 - $183,504	4,389 Added 14.03%	35,676 $1.57 Million
Q2 2018 Jul 16, 2018	SELL	$32.98 - $35.16 $23,085 - $24,611	-700 Reduced 2.19%	31,287 $1.14 Million
Q1 2018 Apr 11, 2018	SELL	$31.91 - $37.02 $41,897 - $48,607	-1,313 Reduced 3.94%	31,987 $1.14 Million
Q4 2017 Jan 10, 2018	BUY	$33.26 - $35.29 $29,102 - $30,878	875 Added 2.7%	33,300 $1.21 Million
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $1.01 Million - $1.11 Million	32,425	32,425 $1.16 Million

Others Institutions Holding PFE

# of Institutions

3,372

Shares Held

3.57B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $124B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.

Account

Franklin Street Advisors Inc Pfizer Inc Transaction History